$118.09 0.8%
Price vs. AI Score (Last 150 days)
Data gathered: December 6

Data Bits

Data Bits Value / Change Benchmark
Job Posts 270 13%
App downloads N/A N/A
Sentiment 78 -3.7%
Webpage traffic 2,401,000 21.4%
Employee Rating 75 0%
Google Adspend $74,182 -34.3%
Google Trends 53 -18.5%
Linkedin Employees 5,989 N/A
Patents 780 0%
4chan Mentions 0%
Facebook Engagement 6,998 3.9%
Facebook followers 187,023 0%
Stocktwits Mentions 5 -16.7%
Stocktwits Subscribers 7,864 0%
Twitter Followers 8,782 -0%
Youtube Subscribers 32,200 0%
Instagram Followers 152,492 0%
News Mentions 0%
Reddit Mentions 0%
Business outlook 71 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Dexcom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.

Price $118.09
Target Price Sign up
Market Cap $45.1B
Dividend Yield 0.0041
Industry Medical Devices

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '23970M638M623M121M247M
Q2 '23865M624M546M116M167M
Q1 '23737M575M463M49M71M
Q4 '22808M608M541M92M145M
Q3 '22765M512M494M101M153M

Insider Transactions

Brown Michael Jon filed to sell 58,394 shares at $115.4.
December 4 '23
Pacelli Steven Robert filed to sell 124,775 shares at $110.8.
November 27 '23
Stern Sadie filed to sell 76,400 shares at $110.
November 24 '23
Naganathan Girish filed to sell 47,725 shares at $93.3.
November 27 '23
Regan Barry J. filed to sell 64,250 shares at $95.2.
November 8 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.